Try our Advanced Search for more refined results
Xellia Pharmaceuticals Inc.
-
Order | Filed: April 24, 2024 | Entered: April 24, 2024 United States of America v. Ben Venue Laboratories, Inc.
Other Statutory Actions | Ohio Northern
Order on Motion to vacate
Order Pending before the Court is Defendant Xellia Pharmaceuticals USA, LLC's Motion to Vacate the Modified Consent Decree of Permanent Injunction. ECF No. 15 . Plaintiff, the United States, filed a response stating that it does not oppose Defendant's motion. ECF No. 18 . Accordingly, the Court grants Defendant's motion. The Modified Consent Decree of Permanent Injunction (ECF No. 14 ) is vacated. Judge Benita Y. Pearson on 4/24/2024. (JLG)
-
Response | Filed: April 23, 2024 | Entered: April 23, 2024 United States of America v. Ben Venue Laboratories, Inc.
Other Statutory Actions | Ohio Northern
Response
Response to 15 Motion to vacate Modified Consent Decree or Permanant Injunction filed by United States of America. (Phelps, Alan)
-
Notice | Filed: April 23, 2024 | Entered: April 23, 2024 United States of America v. Ben Venue Laboratories, Inc.
Other Statutory Actions | Ohio Northern
Attorney Appearance (atty event)
Attorney Appearance by Alan J. Phelps filed by on behalf of United States of America. (Phelps, Alan)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login